|
Slow growing infections may cause or
promote a host of chronic illnesses, including Chronic Fatigue
Syndrome, Fibromyalgia Syndrome and Gulf War Syndrome. Symptoms
such as fatigue, headaches, soreness, joint pain and others
overlap across many chronic illnesses. And patients with
these ailments have few treatment options because of limited
understanding about the cause of their signs and symptoms.
In one study on 203 Chronic Fatigue
Syndrome patients, around 70 percent had mycoplasma DNA
in their bloodstream, indicating the presence of mycoplasmas.
In contrast, only nine percent of 70 healthy individuals
compared carried such signs. Another trial compared 200
Gulf War Syndrome patients to 62 healthy military subjects.
People with the illness were more than seven times more
likely to have mycoplasmal infections.
Mycoplasmas lack many of the features
of more aggressive infectious bacteria, such as cell walls,
than enable antibiotics like penicillins to target invading
germs. Because of their simple structure, mycoplasmas reproduce
slowly, using the machinery of invaded cells to produce
their energy and many of their synthetic molecules. Individuals
with immune systems compromised by viruses, radiation or
pollutants appear to be at risk from mycoplasmal infections.
The breakthrough is using new genetic
tools to find and measure the bacteria. Dr. Garth Nicolson,
the study’s author, has adapted the DNA analysis used
by crime investigators to detect germ genes in each patient's
bloodstream. Once mycoplasmas are identified, Dr. Nicolson
provides antibiotic treatment suggestions to physicians
who then treat their patients.
Two federal efforts based on Dr. Nicolson's
results are now underway to seek to determine whether antibiotics
can cure chronic illness. One, conducted at Walter Reed
Army Medical Center, looks at the blood of Gulf War veterans
for signs of mycoplasmas. The other, conducted at Veterans
Affairs Medical Centers nationwide, involves giving some
mycoplasma-positive Gulf War Syndrome patients antibiotics
and others dummy pills under rigorous experimental conditions
designed to ferret out the true effectiveness of the therapy.
Medical
Sentinel Vol. 4, no. 5, 172-75 September/October 1999
|